After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, TEVA falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $20.71B. A total of 11.32 million shares were traded on the day, compared to an average of 11.26M shares.
In the most recent transaction, Jover Placid sold 6,053 shares of TEVA for 15.16 per share on Aug 01 ’25. After the transaction, the See “Remarks” now owns 6,774 company shares. In a previous transaction on Aug 01 ’25, Hughes Eric A sold 52,742 shares at 15.16 per share. TEVA shares that See “Remarks” owns now total 0.
Among the insiders who bought shares, Jover Placid acquired of 6,053 shares on Aug 01 ’25 at a per-share price of $15.16. In another insider transaction, Hughes Eric A bought 52,742 shares at $15.16 per share on Aug 01 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, TEVA has a high of $22.80 and a low of $12.47.
As of this writing, TEVA has an earnings estimate of $0.67 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $0.71 per share and a lower estimate of $0.66. The company reported an EPS of $0.69 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $5.95, while its Total Shareholder’s Equity was $11.24B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.80.